334 related articles for article (PubMed ID: 27864925)
1. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.
Wu BC; Patel ED; Ortega-Loayza AG
Br J Dermatol; 2017 Jul; 177(1):72-83. PubMed ID: 27864925
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Drug-Induced Pyoderma Gangrenosum: A Review.
Wang JY; French LE; Shear NH; Amiri A; Alavi A
Am J Clin Dermatol; 2018 Feb; 19(1):67-77. PubMed ID: 28624960
[TBL] [Abstract][Full Text] [Related]
4. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
5. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of pyoderma gangrenosum (PG): an updated review.
Braswell SF; Kostopoulos TC; Ortega-Loayza AG
J Am Acad Dermatol; 2015 Oct; 73(4):691-8. PubMed ID: 26253362
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum: a review of pathogenesis and treatment.
Ahn C; Negus D; Huang W
Expert Rev Clin Immunol; 2018 Mar; 14(3):225-233. PubMed ID: 29406827
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports.
Khoshnam-Rad N; Gheymati A; Jahangard-Rafsanjani Z
Anticancer Drugs; 2022 Jan; 33(1):e1-e8. PubMed ID: 34282745
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma Gangrenosum Associated with Sunitinib: A Case Report.
Sevimli Dikicier B
Adv Skin Wound Care; 2019 Sep; 32(9):427-429. PubMed ID: 31408027
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum-a novel approach?
Chokoeva AA; Cardoso JC; Wollina U; Tchernev G
Wien Med Wochenschr; 2017 Mar; 167(3-4):58-65. PubMed ID: 27379854
[TBL] [Abstract][Full Text] [Related]
11. What can inherited immunodeficiencies reveal about pyoderma gangrenosum?
Oprea Y; Kody S; Shakshouk H; Greiling TM; Anstey KM; Ortega-Loayza AG
Exp Dermatol; 2024 Jan; 33(1):e14954. PubMed ID: 37846943
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in managing and understanding pyoderma gangrenosum.
Fletcher J; Alhusayen R; Alavi A
F1000Res; 2019; 8():. PubMed ID: 31885859
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Review of Neutrophilic Diseases.
Marzano AV; Borghi A; Wallach D; Cugno M
Clin Rev Allergy Immunol; 2018 Feb; 54(1):114-130. PubMed ID: 28688013
[TBL] [Abstract][Full Text] [Related]
14. [Pyoderma gangrenosum: case series].
Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.
Rogge FJ; Pacifico M; Kang N
J Plast Reconstr Aesthet Surg; 2008; 61(4):431-3. PubMed ID: 18358433
[TBL] [Abstract][Full Text] [Related]
16. Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature [Formula: see text].
Shavit E; Cecchini M; Limacher JJ; Walsh S; Wentworth A; Davis MDP; Alavi A
J Cutan Med Surg; 2021; 25(4):371-376. PubMed ID: 33541119
[TBL] [Abstract][Full Text] [Related]
17. Current And Emerging Trends In The Management Of Pyoderma Gangrenosum: A Literature Review.
Muhammad SW; Hassan N; Khan S; Gohar A
J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S774-S784. PubMed ID: 38406909
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
Dasanu CA; Bockorny B; Alexandrescu DT
J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pyoderma gangrenosum with methotrexate.
Teitel AD
Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713
[TBL] [Abstract][Full Text] [Related]
20. [Pyoderma gangrenosum in an infant: Case report].
Medeiros CC; Colombari ML; Nassif PW; Gurgel AC; Nassif AE
Dermatol Online J; 2012 Jul; 18(7):6. PubMed ID: 22863628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
